Clinical Trial Update: SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SPD489 in adults with persistent executive function impairments and recurrent major depressive disorder; results completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPD489

Snippet

Sponsor: Shire | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2012-04-06